(Q42415909)

30 October 2017

IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody (English)

1 reference

30 October 2017

7

Andreas von Deimling

1 reference

30 October 2017

2

David Capper

1 reference

30 October 2017

Mindaugas Andrulis

1

1 reference

30 October 2017

Jochen Meyer

3

1 reference

30 October 2017

Roland Penzel

4

1 reference

30 October 2017

Christian Hartmann

5

1 reference

30 October 2017

Hanswalter Zentgraf

6

1 reference

30 October 2017

9 June 2010

1 reference

30 October 2017

1 reference

30 October 2017

95

1 reference

30 October 2017

10

1 reference

30 October 2017

1797-1798

1 reference

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Mutation in TET2 in myeloid cancers

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

The myeloproliferative disorders

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948109

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20534697

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3324/HAEMATOL.2010.024430

1 reference

30 October 2017

1 reference

30 October 2017

PubMed publication ID

20534697

1 reference